Neurology-specific benefit verification extends far beyond confirming active coverage status, because the services neurologists provide are disproportionately subject to prior authorization, specialty-specific coverage limits, and payer routing through specialized benefit management organizations. Most commercial payers route brain MRI and spine MRI authorization requests through radiology benefit management organizations like eviCore or AIM Specialty Health, which apply evidence-based clinical criteria for neurological imaging indications that are separate from the standard payer coverage policy. Authorization requirements for IVIG therapy vary by diagnosis, by payer, and by infusion setting. Botox coverage for chronic migraine may be processed through a specialty prior authorization pathway that differs from the payer's standard PA process. EEG and EMG services require authorization at some commercial plans and not others. CCM enrollment requires patient consent documentation and a specific care plan documentation standard before billing can begin. Neurological conditions frequently require a long-term care trajectory spanning multiple plan years, making ongoing benefit verification essential throughout the treatment relationship rather than a one-time intake function. When verification is superficial, the consequences compound: mid-treatment IVIG denials when coverage lapses, imaging denials when MRIs are ordered without confirming authorization was obtained, and post-service surprises for patients whose cost-sharing structure was never confirmed before treatment began.

Prior authorization in neurology is broader and more payer-specific than in almost any other outpatient specialty, because the services requiring authorization span imaging, therapeutic procedures, infusion therapies, and high-cost disease-modifying treatments for chronic neurological conditions. Neuroimaging authorization through radiology benefit management companies requires documentation of the specific clinical indication, relevant examination findings, and evidence that a lower-cost diagnostic alternative was considered or excluded before the imaging order was placed. For Botox for chronic migraine, the complete authorization package must include prospective headache frequency diary evidence meeting the 15-or-more headache days per month threshold, specific documentation of inadequate response to at least two classes of preventive medications, and a confirmed chronic migraine diagnosis and the specific preventive classes required vary by payer. For IVIG in neurological conditions: nerve conduction study results confirming the diagnosis, electrodiagnostic criteria, clinical presentation documentation, and prior treatment failure evidence are all required components that must be present in the chart before the authorization request is submitted. For disease-modifying therapies in MS, step therapy documentation, prior treatment records, and clinical guideline adherence evidence must accompany each authorization cycle. MedCloudMD builds specialty-specific authorization packages for each neurology service type, tracks payer-specific criteria for each condition and service, and manages proactive renewal workflows so no patient's treatment is interrupted by a preventable authorization gap.

Neurology E/M coding under the 2021 AMA medical decision-making framework is where more neurology revenue is lost than in any other billing category, because the documentation quality of the clinical encounter directly controls reimbursement under MDM-based level selection in a way that earlier E/M guidelines never did as forcefully. High-complexity MDM supporting 99215 requires: a clinical presentation involving multiple chronic illnesses with exacerbation or one illness with severe exacerbation or side effects of treatment, review and analysis of diagnostic data that influenced the management decision, and a management plan with high risk which in neurology most commonly means prescription drug management requiring intensive monitoring for toxicity. A patient with epilepsy on levetiracetam and lacosamide experiencing breakthrough seizures, where the neurologist reviews the most recent EEG findings, assesses both drug levels and drug interaction risk, adjusts the dosing regimen, and documents the clinical reasoning connecting those findings to the management decision, represents textbook high-complexity MDM. But when the note records "seizure management, EEG reviewed, continue meds," the claim processes at 99213 because the MDM documentation is absent even though the clinical work was performed. Our certified neurology coders review documentation against MDM criteria on every encounter, identifying visits where the work supports a higher level than was charged and providing specific feedback to the clinical team so future notes capture the MDM elements the revenue depends on.

EEG billing spans three distinct coding categories, each with its own technical and professional component structure that must be applied correctly based on the care setting and who owns the recording equipment. For routine outpatient EEG, 95816 covers an awake and drowsy recording, 95819 covers awake and asleep, and 95812 and 95813 cover extended monitoring by duration beyond the standard recording. The technical-professional split is the most consequential billing decision in EEG: when the neurologist interprets an EEG recorded at a hospital or outpatient facility that owns the equipment, modifier 26 is appended to the professional component interpretation claim only. When the practice performs both the recording and the interpretation, the global code is billed without a modifier. When the facility bills only for the recording, modifier TC applies. Billing global for a service where only interpretation was performed is an overpayment error that creates audit liability. Long-term continuous EEG monitoring in inpatient settings uses the 95700 through 95726 code series, which encompasses electrode application, monitoring by duration, and physician review and interpretation at defined intervals. Inpatient cEEG billing errors most commonly arise from two sources: misalignment between the billed monitoring duration and the documented monitoring period, and failure to capture daily physician review and interpretation as a separately billable professional service at the correct intervals within the monitoring course.

EMG and nerve conduction study billing generates more systematic coding errors in neurology practices than almost any other diagnostic category, because correct code selection requires information that is often not clearly summarized in the billing charge entry. NCS codes 95907 through 95913 are selected based on the number of individual nerves studied: 95907 for 1 to 2 studies, 95908 for 3 to 4, 95909 for 5 to 6, 95910 for 7 to 8, 95911 for 9 to 10, 95912 for 11 to 12, and 95913 for 13 or more. The critical requirement is that the NCS report must enumerate each individual nerve studied for the tier selection to be accurate a report describing "bilateral upper and lower extremity evaluation" without listing individual nerves leaves the billing team guessing between tiers that may represent meaningful revenue differences across high-volume EMG practices. Needle EMG is coded separately from NCS because it assesses different physiological properties: 95860 for one extremity, 95861 for two extremities, 95863 for three, and 95864 for four extremities. The medical necessity documentation must establish the specific clinical question the study was designed to answer carpal tunnel confirmation, radiculopathy localization, peripheral neuropathy characterization, neuromuscular junction assessment because payers reviewing medical necessity need to connect the ordered study to the documented clinical indication. Our neurology coding team reviews each NCS report for documented nerve study count before assigning the code tier, preventing both undercoding and overcoding on every electrodiagnostic claim.

Botox for chronic migraine and IVIG for inflammatory neuropathies are the two highest-value therapeutic billing categories in neurology, and both require documentation and authorization management that most generalist billing teams have never been trained on. For Botox for chronic migraine, the injection service is billed under CPT 64615 and the drug itself under HCPCS J0585 for onabotulinumtoxinA billed per unit. The PREEMPT protocol calls for a minimum of 155 units administered across 31 fixed injection sites including the frontalis, corrugator, procerus, occipitalis, temporalis, trapezius, and cervical paraspinal muscles, with up to 195 units allowable based on physician clinical assessment. Prior authorization is universally required, and the authorization request must confirm headache frequency diary evidence meeting the chronic migraine definition, documented failure of at least two preventive medication classes, and the NDC of the specific drug lot administered must appear in the clinical record. For IVIG, each formulation has its own J-code: Gamunex-C uses J1566 per 100 mg, Octagam uses J1568 per 500 mg, Gammagard Liquid uses J1569 per 500 mg, Flebogamma uses J1572 per 500 mg, and Privigen uses J1459 per 500 mg. Billing the wrong J-code for the administered formulation results in automatic rejection. Administration is billed under 96365 for the first hour and 96366 for each additional hour. We verify the specific formulation and lot administered before coding every drug claim and manage the full authorization lifecycle for both service categories.

Neurology denials span a broad range of clinical and administrative failure types, each requiring a different appeal strategy built from different clinical evidence. E/M level denials based on documentation insufficiency are the most common source of neurology billing disputes, and reversing them requires identifying the specific MDM elements the documentation already supports and building an appeal that presents those documented facts against the applicable MDM complexity criteria. EMG and NCS medical necessity denials require documentation connecting the clinical indication to the specific physiological question the test was designed to answer. EEG technical-professional component split errors require corrected claims with the correct modifier applied. Botox denials for prior authorization failure or inadequate headache frequency documentation require proactive intervention before the next treatment cycle, not a retroactive appeal. IVIG medical necessity denials require nerve conduction study results, biopsy findings where applicable, and treatment failure documentation specific to the payer's coverage criteria. Modifier 25 denials on procedure-day encounters require coder review of the specific E/M documentation to determine whether the note establishes a distinct clinical service or whether the modifier was applied without supporting documentation. MedCloudMD investigates every neurology denial at its specific root cause before any response is drafted, because the clinical evidence required to reverse a 99215 level dispute is entirely different from what reverses an IVIG authorization failure and treating all denials with the same generic reconsideration approach produces the same generic denial result.

Chronic Care Management revenue is the most consistently missed monthly revenue stream in neurology billing because implementing it requires a workflow that most practices have never built and because its absence doesn't generate any denial or edit that would make the missing revenue visible. The majority of established neurology patient panels are heavily CCM-eligible: epilepsy patients on antiepileptic drug regimens, Parkinson's patients on dopaminergic therapy, MS patients on disease-modifying treatment, Alzheimer's patients requiring coordination across neurology, primary care, and social services, CIDP patients on IVIG, and stroke sequelae patients on anticoagulation all qualify under the two-or-more chronic conditions threshold. CCM billing begins with patient consent, requires a formal care plan maintained and updated in the medical record, and bills monthly when clinical staff document at least 20 minutes of non-face-to-face care coordination per calendar month under 99490, with 99439 for each additional 20-minute increment. MedCloudMD implements the complete CCM program for neurology practices: patient eligibility screening across the active panel, consent documentation workflow, care plan template development, monthly time-tracking system integration, and claim submission for every qualifying patient whose care coordination time is documented each month. Priority-based AR follow-up analytics complement CCM with monthly reporting on E/M level distribution by provider, NCS and EMG tier accuracy, Botox and IVIG authorization rates, and AR aging by service category.